We are a biotechnology company developing advanced spinal stem cell therapeutics to treat patients with diseases of the intervertebral disc.
With back pain being such a significant problem globally and a burden on the healthcare system, our technology has the potential to increase quality of life for patients and to reduce costs to the healthcare system.
A Unique Tool to Battle Back Pain
DiscGenics is the only company to utilize allogeneic therapeutic progenitor cells derived from intervertebral disc within the spine to treat the disc.
A progenitor cell is a partially differentiated adult stem cell.
We have a patented technology for isolating cells directly from adult human disc tissue and expanding these cells into our proprietary Discogenic Cells.